Novel phage derived antimicrobials
Auf einen Blick
- Projektleiter/in : Prof. Dr. Steffi Lehmann
- Stellv. Projektleiter/in : Prof. Dr. Lars Fieseler
- Projektteam : Dr. Lukas Neutsch
- Projektstatus : laufend
- Drittmittelgeber : Innosuisse (Innovationsprojekt / Projekt Nr. 104.969 IP-LS)
- Projektpartner : Micreos GmbH
- Kontaktperson : Steffi Lehmann
Beschreibung
Novel, patentable bacteriophage-based precision antimicrobials are generated. To minimize the risk of failure at the pre-clinical stage, in vivo activity screening in zebrafish embryos is combined with process development, continuous evolution, and phage engineering during early stages of discovery.